Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Journal of Clinical Medicine|May 11, 2024
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional OutcomesFilippo Marino, Stefano Moretto, Francesco Rossi, et al.Journal of Clinical Medicine|July 27, 2024
The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center StudyLuca Di Gianfrancesco, Isabella Monia Montagner, Debora Tormen, et al.World Journal of Urology|March 3, 2025
Antibiotic prophylaxis in stone surgery: a systematic review of the literatureFilippo Gavi, Mauro Ragonese, Daniele Fettucciari, et al.Medicina (Kaunas, Lithuania)|December 23, 2023
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?Pierluigi Russo, Filippo Marino, Francesco Rossi, et al.Cancers|April 27, 2024
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic CenterAngelo Totaro, Eros Scarciglia, Filippo Marino, et al.Cancers|February 10, 2024
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical CystectomyPierluigi Russo, Giuseppe Palermo, Roberto Iacovelli, et al.Cancers|April 13, 2024
Assessing Trifecta and Pentafecta Success Rates between Robot-Assisted vs. Open Radical Cystectomy: A Propensity Score-Matched AnalysisFilippo Gavi, Nazario Foschi, Daniele Fettucciari, et al.Frontiers in Urology|August 8, 2025
Lights and shadows on local recurrence after renal surgery: when, why and how to manageLuca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, et al.Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.Diagnostics (Basel, Switzerland)|October 14, 2023
The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative ReviewLuca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, et al.Pageof 13